| Home > Publications database > An RTX toxin transporters tether ist substrate prior to secretion via the unique function of ist N- terminal domain > print |
| 001 | 23152 | ||
| 005 | 20200402210322.0 | ||
| 024 | 7 | _ | |2 pmid |a pmid:22959622 |
| 024 | 7 | _ | |2 DOI |a 10.1016/j.str.2012.08.005 |
| 024 | 7 | _ | |2 WOS |a WOS:000309787900021 |
| 024 | 7 | _ | |a altmetric:934172 |2 altmetric |
| 037 | _ | _ | |a PreJuSER-23152 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |0 P:(DE-Juel1)VDB94799 |a Lecher, J. |b 0 |u FZJ |
| 245 | _ | _ | |a An RTX toxin transporters tether ist substrate prior to secretion via the unique function of ist N- terminal domain |
| 260 | _ | _ | |a London [u.a.] |b Elsevier Science |c 2012 |
| 300 | _ | _ | |a 1778 - 1787 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |0 26723 |a Structure |v 20 |y 10 |
| 500 | _ | _ | |a Record converted from VDB: 12.11.2012 |
| 520 | _ | _ | |a Type 1 secretion systems (T1SS) catalyze the one step protein transport across the membranes of Gram-negative bacteria and are composed of an outer membrane protein, a membrane fusion protein and an ABC transporter. The ABC transporter consists of the canonical nucleotide binding and transmembrane domains. For the toxin hemolysin A (HlyA), the ABC transporter HlyB carries an additional, N-terminal domain sharing about 40% homology to C39 peptidases, but this "C39-like domain" (CLD) is suggested to feature another, yet unknown function. Our functional and structural analysis demonstrates that the CLD is essential for secretion and that it specifically interacts with the unfolded state of HlyA. We determined the nuclear magnetic resonance structure of the CLD as well as the substrate-binding region within the CLD. This mode of action, represents a mechanism within T1SS and answers the question, how a large and unfolded substrate is protected inside the cells during secretion. |
| 536 | _ | _ | |0 G:(DE-Juel1)FUEK409 |2 G:(DE-HGF) |a Funktion und Dysfunktion des Nervensystems |c P33 |x 0 |
| 536 | _ | _ | |0 G:(DE-Juel1)FUEK505 |a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |c P45 |x 1 |
| 588 | _ | _ | |a Dataset connected to Pubmed |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Schwarz, C.K.W. |b 1 |
| 700 | 1 | _ | |0 P:(DE-Juel1)VDB21601 |a Stoldt, M. |b 2 |u FZJ |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Smits, S.H.J. |b 3 |
| 700 | 1 | _ | |0 P:(DE-Juel1)132029 |a Willbold, D. |b 4 |u FZJ |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Schmitt, L. |b 5 |
| 773 | _ | _ | |0 PERI:(DE-600)2031189-8 |a 10.1016/j.str.2012.08.005 |g Vol. 20, p. 1778 - 1787 |p 1778 - 1787 |q 20<1778 - 1787 |t Structure |v 20 |x 0969-2126 |y 2012 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1016/j.str.2012.08.005 |
| 909 | C | O | |o oai:juser.fz-juelich.de:23152 |p VDB |
| 913 | 1 | _ | |0 G:(DE-Juel1)FUEK409 |1 G:(DE-HGF)POF2-330 |2 G:(DE-HGF)POF2-300 |b Gesundheit |k P33 |l Funktion und Dysfunktion des Nervensystems |v Funktion und Dysfunktion des Nervensystems |x 0 |
| 913 | 1 | _ | |0 G:(DE-Juel1)FUEK505 |1 G:(DE-HGF)POF2-450 |2 G:(DE-HGF)POF2-400 |b Schlüsseltechnologien |k P45 |l Biologische Informationsverarbeitung |v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |x 1 |
| 913 | 2 | _ | |0 G:(DE-HGF)POF3-551 |1 G:(DE-HGF)POF3-550 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |v Functional Macromolecules and Complexes |x 0 |
| 914 | 1 | _ | |y 2012 |
| 915 | _ | _ | |a Peer review unknown |0 StatID:(DE-HGF)0040 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 920 | 1 | _ | |0 I:(DE-Juel1)ICS-6-20110106 |g ICS |k ICS-6 |l Strukturbiochemie |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)140117 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|